Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Exelixis Inc (EXEL), most recent 12 months reported: revenue $2.44B, net income $860.62M, free cash flow $1.17B. Latest balance sheet on file: liquid cash $839.38M. From SEC filings. More on Exelixis Inc: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): Amgen Inc. · GILEAD SCIENCES, INC. · BIOGEN INC. · NEUROCRINE BIOSCIENCES INC · Moderna, Inc. · QIAGEN N.V. · HALOZYME THERAPEUTICS, INC. · BIO-TECHNE Corp
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.